For more than 30 years, SERB Pharmaceuticals, as a specialized pharmaceutical laboratory, has made available emergency medications and CBRN antidotes covering the main risks: cyanide, nerve agents, radiological and nuclear threats, as well as cutaneous decontamination medical devices.

With a historical presence in Europe, today extended to the United States and the Middle East, and relying on a global network of partners, SERB makes these critical countermeasures accessible in more than 100 countries.

From design to marketing, SERB manages the entire lifecycle of its health solutions and establishes itself as a strategic partner in risk preparedness, strategic stockpiling, and support for emergency situations and crisis response, contributing to the protection of both civilian populations and the armed forces.